AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N93019C00052UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Overview
Award facts
- Net obligations
- $76.79M
- $76,786,980of $118.15M potential value
- Outlays (paid to date)
- $51.40M
- $51.40M paid of $76.79M obligated$51,401,091
- Period of performance
- Sep 10, 2019 to Sep 9, 2027
- Ends in 9 months
- Modifications
- 30
- Latest action Jun 25, 2026
- Contract type
- Definitive contract
- PIID 75N93019C00052
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST AND BROADLY PROTECTIVE IMMU
Dates and value
- Award date
- Signed on Sep 6, 2019
- Current value
- $76,786,980Base and exercised options
- Potential value (if all options are exercised)
- $118,147,453
Obligations by fiscal year of action
- FY2026: $2,218,092
- FY2025: $8,000,000
- FY2024: $8,849,325
- FY2023: $10,700,042
- FY2022: $12,478,853
- FY2021: $13,851,457
- FY2020: $12,689,211
- FY2019: $8,000,000
Total across 8 fiscal years: $76,786,980
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 25, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationATHENS, GA
UEINMJHD63STRC5
CAGE code07DC3
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyUNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC.
Business types and certifications
Nonprofit organizationTax-exempt corporation
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National cancer institute (0849); National institute of allergy and infectious diseases (0885)Program activities075-0849, 075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Athens, Clarke County, Georgia 30602-5016
- Congressional district (place of performance)
- GA-10As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost no feeS
- Offers received
- 9
Solicitation and notices
- Solicitation ID
- HHSNIHNIAIDBAA2018(as reported)
- Solicitation date
- Jul 3, 2018
Contract details
- Subcontracting plan
- Individual subcontract planF
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 6, 2019Base obligation at award: $8,000,000
- Latest action
- Jun 25, 2026 — Option exercisedModification P00030; obligation change +$2,218,092
- Latest substantive action
- Jun 25, 2026 — Option exercisedModification P00030; obligation change +$2,218,092
- Actions by type
- Base award1
- Option exercised12
- Other administrative action11
- Change order7
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $2,218,092
- Latest action: change in base and all options
- -$2,082,510
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 31
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2019/2019-0885-000
- 075-2020/2020-0885-000
- 075-2020/2024-0885-000
- 075-2021/2021-0885-000
- 075-2022/2022-0885-000
- 075-2023/2023-0885-000
Show all 9 accounts
- 075-2024/2024-0885-000
- 075-2025/2025-0885-000
- 075-X-0849-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- P: Emergency P.L. 116-139
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $3,515,268
- COVID-19 supplemental outlays
- $3,300,446